The neuronal channelopathies
The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Abstract
This review addresses the molecular and cellular mechanisms of diseases caused by inherited mutations of ion channels in neurones. Among important recent advances is the elucidation of several dominantly inherited epilepsies caused by mutations of both voltage-gated and ligand-gated ion channels. The neuronal channelopathies show evidence of phenotypic convergence; notably, episodic ataxia can be caused by mutations of either calcium or potassium channels. The channelopathies also show evidence of phenotypic divergence; for instance, different mutations of the same calcium channel gene are associated with familial hemiplegic migraine, episodic or progressive ataxia, coma and epilepsy. Future developments are likely to include the discovery of other ion channel genes associated with inherited and sporadic CNS disorders. The full range of manifestations of inherited ion channel mutations remains to be established.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Defects in ion channels underlie many major disorders in humans, also known as channelopathies, including neuronal disorders76, diabetes77 and heart failure78.”
From Unexplored therapeutic opportunities in the human genome (2018) · cites this paper as [76]
Citations
Cites
Ion Channels/Excitable Membranes
(2011) · SpringerReference · doi:10.1007/springerreference_33998 · Cited by 4,034
Structure and Regulation of Voltage-Gated Ca 2+ Channels
Catterall, W. A. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.521 · Cited by 2,344 · cited 3×
“The a 1A subunit forms the voltage sensor and pore of the channel, and is associated with b, a 2 d and possibly g accessory subunits, which target and/or anchor it to the membrane, modulate its voltage-dependent kinetics, and play a role in G protein-mediated modulation (Catterall, 2000b).”
Ophoff, R. A., Terwindt, G. M., Vergouwe, M. N., van Eijk, R., Oefner, P. J., Hoffman, S. M. G., Lamerdin, J. E., Mohrenweiser, H. W., Bulman, D. E., Ferrari, M., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81373-2 · Cited by 2,339 · cited 9×
“A recent surprising ®nding is the association of CACNA1A mutations with fatal cerebral oedema triggered by minor head trauma (Kors et al., 2001).”
InfluentialFrom Ionic Currents to Molecular Mechanisms
Catterall, W. A. (2000) · Neuron · doi:10.1016/s0896-6273(00)81133-2 · Cited by 2,118 · cited 3×
“The a 1A subunit forms the voltage sensor and pore of the channel, and is associated with b, a 2 d and possibly g accessory subunits, which target and/or anchor it to the membrane, modulate its voltage-dependent kinetics, and play a role in G protein-mediated modulation (Catterall, 2000b).”
Zhuchenko, O., Bailey, J., Bonnen, P., Ashizawa, T., Stockton, D. W., Amos, C., Dobyns, W. B., Subramony, S. H., Zoghbi, H. Y., & Lee, C. C. (1997) · Nature Genetics · doi:10.1038/ng0197-62 · Cited by 1,583 · cited 4×
“SCA6 is unique among the channelopathies in that it is generally caused by an expansion of a polyglutamine repeat in the intracellular C-terminus of the channel (Zhuchenko et al., 1997).”
InfluentialMuscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone
Brown, D. A., & Adams, P. R. (1980) · Nature · doi:10.1038/283673a0 · Cited by 1,444 · cited 1×
“Cholinergic agonists acting through these G protein-coupled receptors inhibit the so-called`M current', a low-threshold, noninactivating , voltage-dependent potassium current (Brown and Adams, 1980).”
KCNQ2 and KCNQ3 Potassium Channel Subunits: Molecular Correlates of the M-Channel
Wang, H. (1998) · Science · doi:10.1126/science.282.5395.1890 · Cited by 1,294 · cited 2×
“The current mediated by KCNQ2/KCNQ3 channels has an activation threshold and kinetics similar to the M current, and is suppressed when expressed together with muscarinic receptors (Wang et al., 1998; Selyanko et al., 1999; Shapiro et al., 2000).”
De Novo Mutations in the Sodium-Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of Infancy
Claes, L., Del-Favero, J., Ceulemans, B., Lagae, L., Van Broeckhoven, C., & De Jonghe, P. (2001) · The American Journal of Human Genetics · doi:10.1086/320609 · Cited by 1,292 · cited 4×
“In the light of this evidence, a recent study of several patients with severe myoclonic epilepsy of infancy (SMEI) presents surprising results (Claes et al., 2001).”
InfluentialA novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns
Singh, N. A., Charlier, C., Stauffer, D., DuPont, B. R., Leach, R. J., Melis, R., Ronen, G. M., Bjerre, I., Quattlebaum, T., Murphy, J. V., et al. (1998) · Nature Genetics · doi:10.1038/ng0198-25 · Cited by 1,199 · cited 10×
“The potassium channel KCNQ2 was discovered by positional cloning on chromosome 20 (Biervert et al., 1998; Singh et al., 1998), and homology screening then revealed that a closely related channel KCNQ3 occurs at the locus on chromosome 8 (Charlier et al.”
InfluentialSteinlein, O. K., Mulley, J. C., Propping, P., Wallace, R. H., Phillips, H. A., Sutherland, G. R., Scheffer, I. E., & Berkovic, S. F. (1995) · Nature Genetics · doi:10.1038/ng1095-201 · Cited by 1,134 · cited 2×
“A role for the a4 subunit in epilepsy was demonstrated by the ®nding that a family with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) harbours a heterozygous missense mutation in the gene CHRNA4 on chromosome 20 (Steinlein et al., 1995).”
Research works printed but not linked: 2
- Lerche H, Biervert C, Alekov AK, Schleithoff L, Lindner M, Klinger W, et al. A reduced K+ current due to a novel mutation in KCNQ2 causes neonatal convulsions. Ann Neurol1999; 46: 305–12. · doi:10.1002/1531-8249(199909)46:3<305::aid-ana5>3.0.co;2-5
- Vergouwe MN, Tijssen MA, Peters AC, Wielaard R, Frants RR. Hyperekplexia phenotype due to compound heterozygosity for GLRA1 gene mutations. Ann Neurol1999; 46: 634–8. · doi:10.1002/1531-8249(199910)46:4<634::aid-ana12>3.0.co;2-9
Cited by
Chang, B. S., & Lowenstein, D. H. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022308 · Cited by 731
Dendritic Excitability and Synaptic Plasticity
Sjöström, P. J., Rancz, E. A., Roth, A., & Häusser, M. (2008) · Physiological Reviews · doi:10.1152/physrev.00016.2007 · Cited by 725
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions
Rogawski, M. A., & Löscher, W. (2004) · Nature Medicine · doi:10.1038/nm1074 · Cited by 456
“Thus, these channels are appropriately placed to account for the neuromyotonia and cerebellar dysfunction and also the seizures that occur in some forms of episodic ataxi”
Acquired Dendritic Channelopathy in Temporal Lobe Epilepsy
Bernard, C., Anderson, A., Becker, A., Poolos, N. P., Beck, H., & Johnston, D. (2004) · Science · doi:10.1126/science.1097065 · Cited by 449
Unexplored therapeutic opportunities in the human genome
Oprea, T. I., Bologa, C. G., Brunak, S., Campbell, A., Gan, G. N., Gaulton, A., Gomez, S. M., Guha, R., Hersey, A., Holmes, J., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.14 · Cited by 378
Erratum: Unexplored therapeutic opportunities in the human genome
Oprea, T. I., Bologa, C. G., Brunak, S., Campbell, A., Gan, G. N., Gaulton, A., Gomez, S. M., Guha, R., Hersey, A., Holmes, J., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.52 · Cited by 311
Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine
Strupp, M., Kalla, R., Dichgans, M., Freilinger, T., Glasauer, S., & Brandt, T. (2004) · Neurology · doi:10.1212/01.wnl.0000125691.74109.53 · Cited by 253
Fernández-Fernández, J. M., Tomás, M., Vázquez, E., Orio, P., Latorre, R., Sentí, M., Marrugat, J., & Valverde, M. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20347 · Cited by 184
“dominant effect when the mutant allele is coexpressed with the wild-type allele has already been reported for other channels (38).”
E-I balance and human diseases – from molecules to networking
Eichler, S. A. (2008) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.002.2008 · Cited by 167
“For example, epilepsy-associated mutations were found in GABA(A) receptor (GABRG2), sodium (SCN1, SCN2), potassium (KCNA, KCNQ) and calcium channel (CACNA1A) genes (Kullmann, 2002; Scheffer and Berkovic, 2003; Sloviter, 1987).”
BackgroundPotassium Channels in Epilepsy
Köhling, R., & Wolfart, J. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022871 · Cited by 161
“Here, we briefly summarize the known genetic mutations associated with epilepsies in humans (for more detailed accounts, see Jentsch 2000; Kullmann 2002; Mulley et al. 2003; George 2004; Steinlein 2004; Brenner and Wilcox 2012; D’Adamo et al. 2013; Lerche et al. 2013).”
BackgroundNon-Equilibrium Gating in Cardiac Na + Channels: An Original Mechanism of Arrhythmia
Clancy, C. E., Tateyama, M., Liu, H., Wehrens, X. H. T., & Kass, R. S. (2003) · Circulation · doi:10.1161/01.cir.0000069273.51375.bd · Cited by 151
Johnson, B. A. (2005) · CNS Drugs · doi:10.2165/00023210-200519100-00005 · Cited by 145
High Throughput Ion-Channel Pharmacology: Planar-Array-Based Voltage Clamp
Kiss, L., Bennett, P. B., Uebele, V. N., Koblan, K. S., Kane, S. A., Neagle, B., & Schroeder, K. S. (2003) · Assay and Drug Development Technologies · doi:10.1089/154065803321537845 · Cited by 142
The pathophysiology of migraine: year 2005
Buzzi, M. G., & Moskowitz, M. A. (2005) · The Journal of Headache and Pain · doi:10.1007/s10194-005-0165-2 · Cited by 135
Shafer, T. J., & Meyer, D. A. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.12.013 · Cited by 134
High Throughput Assay Technologies for Ion Channel Drug Discovery
Zheng, W., Spencer, R. H., & Kiss, L. (2004) · Assay and Drug Development Technologies · doi:10.1089/1540658042584143 · Cited by 132
Abramovici, S., & Bagic, A. I. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802973-2.00010-0 · Cited by 128
Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations
Wuttke, T. V., Jurkat-Rott, K., Paulus, W., Garncarek, M., Lehmann-Horn, F., & Lerche, H. (2007) · Neurology · doi:10.1212/01.wnl.0000275523.95103.36 · Cited by 109
Episodic Ataxia Type 1: A Neuronal Potassium Channelopathy
Rajakulendran, S., Schorge, S., Kullmann, D. M., & Hanna, M. G. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.01.010 · Cited by 116
Self-citationSignificant linkage to migraine with aura on chromosome 11q24
Cader, M. Z., Noble-Topham, S., Dyment, D. A., Cherny, S. S., Brown, J., Rice, G. P., & Ebers, G. C. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg252 · Cited by 115
“Mutations in neuronally expressed potassium channels cause autosomal dominant paroxysmal movement disorders such as benign familial neonatal convulsions and episodic ataxia type 1 (46).”
BackgroundMesial temporal lobe epilepsy: A pathological replay of developmental mechanisms?
Cohen, I., Navarro, V., Le Duigou, C., & Miles, R. (2003) · Biology of the Cell · doi:10.1016/s0248-4900(03)00081-9 · Cited by 89
Redaelli, E., Cassulini, R. R., Silva, D. F., Clement, H. C., Schiavon, E., Zamudio, F. Z., Odell, G. V., Arcangeli, A., Clare, J. J., Alagon, A. C., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.054718 · Cited by 99
Advances in understanding basic mechanisms of epilepsy and seizures
Jefferys, J. G. R. (2010) · Seizure · doi:10.1016/j.seizure.2010.10.026 · Cited by 99
Mouse models for psychiatric disorders
Seong, E., Seasholtz, A. F., & Burmeister, M. (2002) · Trends in Genetics · doi:10.1016/s0168-9525(02)02807-x · Cited by 98
Thiffault, I., Speca, D. J., Austin, D. C., Cobb, M. M., Eum, K. S., Safina, N. P., Grote, L. E., Farrow, E., Miller, N., Soden, S. E., et al. (2015) · The Journal of General Physiology · doi:10.1085/jgp.201511444 · Cited by 92
Optogenetic photochemical control of designer K+channels in mammalian neurons
Fortin, D. L., Dunn, T., Fedorchak, A. V., Allen, D., Montpetit, R., Banghart, M. R., Trauner, D. H., Adelman, J. P., & Krämer, R. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00251.2011 · Cited by 88
Neurological disorders caused by inherited ion-channel mutations
Kullmann, D. M., & Hanna, M. G. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00071-6 · Cited by 87
Self-citationDegeneracy in hippocampal physiology and plasticity
Rathour, R. K., & Narayanan, R. (2019) · Hippocampus · doi:10.1002/hipo.23139 · Cited by 72
“…2007; Johnston et al., 2003; Johnston et al., 2016; Johnston et al., 1996; Johnston and Narayanan, 2008; Kerti et al., 2012; Kirizs et al., 2014; Kullmann, 2002; Lai and Jan, 2006; Lerche et al., 2013; Lorincz et al., 2002; Lorincz and Nusser, 2010; Magee, 1998; Magee and Cook, 2000; Magee and…”
BackgroundOvsepian, S. V., Berre, M. L., Steuber, V., O’Leary, V. B., Leibold, C., & Dolly, J. O. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.01.005 · Cited by 82
“1 subunit (Imbrici, D'Adamo, Kullmann, & Pessia, 2006; Kullmann, 2002; Kullmann, Rea, Spauschus, & Jouvenceau, 2001; Rajakulendran, Schorge, Kullmann, & Hanna, 2007).”
BackgroundToxic Role of K+Channel Oxidation in Mammalian Brain
Cotella, D., Hernández-Enríquez, B., Wu, X., Li, R., Pan, Z., Leveille, J., Link, C. D., Oddo, S., & Sesti, F. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6153-11.2012 · Cited by 80
“For example, mutations in KCNQ2, KCNQ3, KCNMA1, KCNA1 and KCNC3 genes which lead to the synthesis of mutants with defective properties have been identified in patients affected by epilepsy, ataxia and episodic ataxia type 1 (for review, see Kullmann, 2002).”
BackgroundLi, S., Kalappa, B. I., & Tzounopoulos, T. (2015) · eLife · doi:10.7554/elife.07242 · Cited by 79
Relationship Between Migraine and Epilepsy in Pediatric Age
Piccinelli, P., Borgatti, R., Nicoli, F., Calcagno, P., Bassi, M. T., Quadrelli, M., Rossi, G., Lanzi, G., & Balottin, U. (2006) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00373.x · Cited by 67
Aminopyridines for the treatment of cerebellar and ocular motor disorders
Strupp, M. L., Kalla, R., Glasauer, S., Wagner, J. N., Hüfner, K., Jahn, K., & Brandt, T. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00676-6 · Cited by 67
Toxin insights into nicotinic acetylcholine receptors
Dutertre, S., & Lewis, R. J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.03.027 · Cited by 67
Low-Frequency Oscillations in the Cerebellar Cortex of the Tottering Mouse
Chen, G., Popa, L. S., Wang, X., Gao, W., Barnes, J. A., Hendrix, C. M., Hess, E. J., & Ebner, T. J. (2008) · Journal of Neurophysiology · doi:10.1152/jn.90829.2008 · Cited by 65
Lee, H., Jen, J. C., Wang, H., Chen, Z., Mamsa, H., Sabatti, C., Baloh, R. W., & Nelson, S. F. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi441 · Cited by 65
“We speculate that ion channels or channel-associated proteins (21) within these regions of linkage would be primary candidates for sequence and association analysis.”
BackgroundPeña‐Ortega, F., & Alavez-Pérez, N. S. (2006) · Epilepsia · doi:10.1111/j.1528-1167.2006.00369.x · Cited by 62
“The EEG is attenuated at the onset, followed by slow waves, spikes, and a burst-suppression pattern (25).”
BackgroundThe Use of Aminopyridines in Neurological Disorders
Sedehizadeh, S., Keogh, M. J., & Maddison, P. (2012) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e31825a68c5 · Cited by 59
Weiergräber, M., Kamp, M. A., RADHAKRISHNAN, K., Hescheler, J., & Schneider, T. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.07.004 · Cited by 59
Acquired neuronal channelopathies in HIV-associated dementia
Gelman, B. B., Soukup, V. M., Schuenke, K. W., Keherly, M. J., Holzer, C. E., Richey, F. J., & Lahart, C. J. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.08.044 · Cited by 55
“Inherited mutations of ion channels usually produce overexcitation including brain seizures, muscle spasticity or cardiac dysrhythmia (Kullmann, 2002).”
BackgroundTRPM3 in Brain (Patho)Physiology
Held, K., & Tóth, B. I. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.635659 · Cited by 54
“For this reason, ion channels are primary targets for pharmacological interventions to treat such diseases (Kullmann, 2002; Kumar et al., 2016).”
BackgroundReview: Current treatment of vestibular, ocular motor disorders and nystagmus
Strupp, M. L., & Brandt, T. (2009) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285609103120 · Cited by 52
“Episodic ataxia type 2 (EA2) is clinically characterised by recurrent attacks of ataxia, provoked by stress or exercise, which last for several hours to days [Strupp et al. 2007b; Jen et al. 2004; Griggs and Nutt, 1995].”
BackgroundInfluentialMarchant, C. L., ELLIS, F. R., Halsall, P. J., Hopkins, P. M., & Robinson, R. L. (2004) · Muscle & Nerve · doi:10.1002/mus.20068 · Cited by 52
Alternating and Postictal Psychoses: Review and a Unifying Hypothesis
Sachdev, P. S. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm012 · Cited by 51
“This field is moving rapidly, but it is as yet not understood what role channel abnormalities play in the common forms of temporal lobe and primary generalized epilepsies and how they are regulated to produce spontaneous cessation of seizures.(81) The effect of ion channel abnormalities on neurotransmitter release and…”
BackgroundActive Dendrites and Local Field Potentials: Biophysical Mechanisms and Computational Explorations
Sinha, M., & Narayanan, R. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.08.035 · Cited by 49
“Careful experimentation assessing ion channels involved in dendritic information processing has revealed dramatic pathological changes in their composition and densities (Kullmann, 2002 (Buzsaki et al., 2012; Einevoll et al., 2013).”
Medical treatment of vestibular disorders
Brandt, T., Zwergal, A., & Strupp, M. L. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902976879 · Cited by 49
“On the basis of the functional changes of the PQ-channel mutation, which leads to a reduced calcium current, it can be assumed that the inhibitory effect of Purkinje cells is reduced in EA2 [84].”
BackgroundInfluentialNeuropathology in Drosophila Membrane Excitability Mutants
Fergestad, T., Ganetzky, B., & Palladino, M. J. (2005) · Genetics · doi:10.1534/genetics.105.050625 · Cited by 49
mechanisms of disease Epilepsy
Chang, B. S., & Lowenstein, D. H. (2003) · Cited by 47
Enhancing M currents: a way out for neuropathic pain?
Rivera‐Arconada, I., Roza, C., & Lopez-Garcia, J. A. (2009) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.010.2009 · Cited by 44
“Genetic defects in genes coding potassium channel subunits have been related to human diseases indicating the great importance that they have in cellular and systems physiology (Kullmann, 2002).”
Determination of α‐conotoxin binding modes on neuronal nicotinic acetylcholine receptors
Dutertre, S., Nicke, A., Tyndall, J. D. A., & Lewis, R. J. (2004) · Journal of Molecular Recognition · doi:10.1002/jmr.683 · Cited by 43
“…and modulation of membrane potentials and are involved in a wide variety of noninherited as well as inherited disorders (channelopathies) (Kullmann, 2002). nAChRs, pentameric transmembrane proteins, belong to a family of ligand-gated ion channels and open in response to ACh binding…”
BackgroundPharmacological advances in the treatment of neuro-otological and eye movement disorders
Strupp, M. L., & Brandt, T. (2006) · Current Opinion in Neurology · doi:10.1097/01.wco.0000196156.00481.e1 · Cited by 42
Genetic neurological channelopathies
Hanna, M. G. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0178 · Cited by 41
Patel, K. A., Bartoli, K. M., Fandino, R. A., Ngatchou, A. N., Woch, G., Carey, J., & Tanaka, J. C. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0179 · Cited by 40
“Studies of human disease mutations have provided a growing list of channelopathies in which protein retention in the ER is now recognized as a major cause.(11) Examples of such trafficking defects occur in the human rod CNGA1 in an autosomal recessive form of retinitis pigmentosa,(37,38) the F508 cystic fibrosis trans…”
Schiavon, E., Pedraza‐Escalona, M., Gurrola, G. B., Olamendi‐Portugal, T., Corzo, G. A., Wanke, E., & Possani, L. D. (2011) · Toxicon · doi:10.1016/j.toxicon.2011.12.003 · Cited by 39
de Lahunta, A., & Glass, E. N. (2009) · Elsevier eBooks · doi:10.1016/b978-0-7216-6706-5.00008-1 · Cited by 39
Synthesis and functional studies of THF–gramicidin hybrid ion channels
Vescovi, A., Knoll, A., & Koert, U. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b303249n · Cited by 39
Voltage‐gated sodium channel isoform‐specific effects of pompilidotoxins
Schiavon, E., Stevens, M., Zaharenko, A. J., Konno, K., Tytgat, J., & Wanke, E. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07533.x · Cited by 37
Altered thalamocortical rhythmicity in Cav2.3-deficient mice
Weiergräber, M., Henry, M., Ho, M. S. P., Struck, H., Hescheler, J., & Schneider, T. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.08.007 · Cited by 36
Hamann, M., Meisler, M. H., & Richter, A. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00290-5 · Cited by 34
The Clinical Spectrum of Autosomal‐Dominant Episodic Ataxias
Kipfer, S., & Strupp, M. (2014) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12075 · Cited by 33
“Because EA 2 is most often caused by loss-of-function mutations, it is associated with reduced calcium currents.57 Mutant channels probably lead to an altered or reduced calcium-dependent neurotransmitter release, which, in turn, leads to altered intrinsic firing properties of the inhibitory effect of GABA-ergic PCs.5…”
BackgroundArthropod toxins acting on neuronal potassium channels
Jiménez-Vargas, J. M., Possani, L. D., & Luna-Ramírez, K. S. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.09.025 · Cited by 32
“This event induces a durable depolarization of the nervous system and provokes release of pro-inflammatory cytokines causing neurodegenerative processes (Kullmann, 2002; Brenner and Wilcox, 2012).”
Rochette, J., Roll, P., & Szepetowski, P. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.059519 · Cited by 30
“…familial co-inheritance all argue in favour of close relationships between various epileptic syndromes and other paroxysmal disorders of the brain, 35 such as migraine, episodic ataxia and, as mentioned above, PD. 38 Similarly, the existence of links between the epilepsies and non-paroxysmal…”
BackgroundKobayashi, T., Tagawa, A., Noda, T., Sasagawa, K., Tokuda, T., Hatanaka, Y., Tamura, H., Ishikawa, Y., Shiosaka, S., & Ohta, J. (2010) · Japanese Journal of Applied Physics · doi:10.1143/jjap.49.117001 · Cited by 27
Anterior Cingulate epilepsy: mechanisms and modulation
Chang, W., & Shyu, B. (2014) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00104 · Cited by 27
“Frontiers in Integrative Neuroscience www.frontiersin.org January 2014 | Volume 7 | Article 104 | 3 “fnint-07-00104” — 2013/12/30 — 17:22 — page 4 — #4 channelopathies (Kullmann, 2002), and alterations in transmitter uptake (Chapman, 1998; Rainesalo et al., 2004).”
BackgroundEfficient phase coding in hippocampal place cells
Seenivasan, P., & Narayanan, R. (2020) · Physical Review Research · doi:10.1103/physrevresearch.2.033393 · Cited by 25
Kullmann, D. M. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.suppl_2.ii32 · Cited by 25
“Several families exhibiting epilepsy transmitted in a mendelian manner have recently been found to have mutations in single genes. They are all dominantly inherited and all but one of them code for ion channels, underlining the importance of this class of signalling protein in determining the excitability of neuronal…”
BackgroundSelf-citationStructural Effects of an LQT-3 Mutation on Heart Na+ Channel Gating
Tateyama, M., Liu, H., Yang, A.-S., Cormier, J. W., & Kass, R. S. (2004) · Biophysical Journal · doi:10.1016/s0006-3495(04)74251-4 · Cited by 24
“…the disorders caused by them, including epilepsy, febrile seizures, Dent’s disease, and cardiac arrhythmias, are now referred to as channelopathies (Marban, 2002; Jentsch, 2000; Jentsch et al., 2000; Schwake et al., 2001; Lossin et al., 2002; Jurkat-Rott and Lehmann-Horn, 2001; Kullmann, 2002).”
BackgroundAdvances in the Pathophysiology of Developmental Epilepsies
Wong, M. (2005) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2005.03.002 · Cited by 24
Mishra, P., & Narayanan, R. (2021) · Current Research in Neurobiology · doi:10.1016/j.crneur.2021.100007 · Cited by 23
Channeling Studies in Yeast: Yeast as a Model for Channelopathies?
Wolfe, D. M., & Pearce, D. A. (2006) · NeuroMolecular Medicine · doi:10.1385/nmm:8:3:279 · Cited by 23
Axonal function in a family with episodic ataxia type 2 due to a novel mutation
Krishnan, A. V., Bostock, H., Ip, J., Hayes, M., Watson, S. R. D., & Kiernan, M. C. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0794-x · Cited by 23
“These changes may cause a reduction in the inhibitory effect of Purkinje cells and subsequent disinhibition of deep cerebellar nuclei, leading to ataxia and nystagmus [3, 15, 25].”
BackgroundSpekker, E., Nagy-Grócz, G., & Vécsei, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316574 · Cited by 23
“In recent decades, the importance of ion channels in the pathogenesis of migraine has received considerable attention, as an altered ion channel function can be observed in many neurological diseases [29].”
BackgroundDe novo KCNA6 variants with attenuated KV 1.6 channel deactivation in patients with epilepsy
Salpietro, V., Deforie, V. G., Efthymiou, S., O’Connor, E., Marcé‐Grau, A., Maroofian, R., Striano, P., Zara, F., Morrow, M. M., SYNAPS Study Group, et al. (2022) · Epilepsia · doi:10.1111/epi.17455 · Cited by 22
“11,12 The K V 1 ( KCNA ) subfamily comprises eight homologous subunits (K V 1.1-”
InfluentialSelf-citationHiggins, A., Downes, C., Varley, J., Doherty, C. P., Begley, C., & Elliott, N. (2019) · Journal of Nursing Management · doi:10.1111/jonm.12747 · Cited by 22
In Vitro Folding of KvAP, a Voltage-Gated K+ Channel
Devaraneni, P. K., Devereaux, J., & Valiyaveetil, F. I. (2011) · Biochemistry · doi:10.1021/bi2012965 · Cited by 22
Zaharenko, A. J., Schiavon, E., Ferreira, W. A., Lecchi, M., de Freitas, J. C., Richardson, M., & Wanke, E. (2011) · Peptides · doi:10.1016/j.peptides.2011.07.008 · Cited by 22
Genetic Mechanisms of Migraine: Insights from Monogenic Migraine Mutations
Gosalia, H., Karsan, N., & Goadsby, P. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612697 · Cited by 21
Yadollahpour, A., Firouzabadi, S. M., Shahpari, M., & Mirnajafi‐Zadeh, J. (2013) · Epilepsy Research · doi:10.1016/j.eplepsyres.2013.11.023 · Cited by 21
Ahras-Sifi, N., Martin‐Eauclaire, M., & Laraba‐Djebari, F. (2016) · Inflammation Research · doi:10.1007/s00011-016-0945-y · Cited by 21
“Binding of KTX to its specific receptor, the voltage-dependent potassium channels, lead to their blockade and prevents the release of K ions in the extracellular environment, this event induces a durable depolarization of the nervous system (hyperexcitability) characterized by seizures [31, 32].”
BackgroundMartins, I., & Gil‐Gouveia, R. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01297.x · Cited by 21
Inherited neuromyotonia: A clinical and genetic study of a family
Falace, A., Striano, P., Manganelli, F., Coppola, A., Striano, S., Minetti, C., & Zara, F. (2006) · Neuromuscular Disorders · doi:10.1016/j.nmd.2006.09.014 · Cited by 20
Contribution of Axon Initial Segment Structure and Channels to Brain Pathology
Garrido, J. J. (2023) · Cells · doi:10.3390/cells12081210 · Cited by 19
“Mutations in these channels are associated with brain diseases or mental disorders [3]; however, alterations of their density, location, or scaffold proteins are also a potential cause of brain diseases.”
Migraine prophylactic drugs work via ion channels
Cohen, G. L. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.01.027 · Cited by 19
Channelopathies of the Nervous System
Cleland, J. C., & Griggs, R. C. (2007) · Elsevier eBooks · doi:10.1016/b978-012088592-3/50033-5 · Cited by 18
Reduced ACh release at neuromuscular synapses of heterozygous leaner Cav2.1‐mutant mice
Kaja, S., van de Ven, R. C. G., Frants, R. R., Ferrari, M. D., van den Maagdenberg, A. M. J. M., & Plomp, J. J. (2008) · Synapse · doi:10.1002/syn.20490 · Cited by 17
“Episodic ataxia type 2 (EA2) is an autosomal dominantly inherited neurological disorder characterized by symptoms of ataxia, nystagmus, dysarthria, vertigo, diplopia, and general weakness (OMIM #108500; for reviews see Kullmann, 2002; Pietrobon, 2002; Strupp et al., 2007).”
Zhu, J., Alsaber, R., Zhao, J., Ribeiro-Hurley, E. M., & Thornhill, W. B. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.05.006 · Cited by 17
Goadsby, P. J., & Kullmann, D. M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66787-6 · Cited by 17
Self-citationCryptic causation of human disease: reading between the (germ) lines
Weiss, K. M. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.12.008 · Cited by 17
Jiménez-Garduño, A. M., Juárez-Hernández, L. J., Polanco, M. J., Tosatto, L., Michelatti, D., Arosio, D., Basso, M., Pennuto, M., & Musio, C. (2017) · Biophysical Chemistry · doi:10.1016/j.bpc.2017.05.003 · Cited by 16
Involvement of Potassium Channel Signalling in Migraine Pathophysiology
Al‐Karagholi, M. A. (2023) · Pharmaceuticals · doi:10.3390/ph16030438 · Cited by 16
“Altered ion channel function causes a range of neurological diseases known as channelopathies, such as epilepsy and episodic ataxia [10].”
BackgroundInfluentialUncontrolled Involuntary Skeletal Muscle Contractions
de Lahunta, A., Glass, E. N., & Kent, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-69611-1.00020-7 · Cited by 16
Koch, N. A., Sonnenberg, L., Hedrich, U. B. S., Lauxmann, S., & Benda, J. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1194811 · Cited by 15
“Ion channel variants are frequently classified in heterologous expression systems as either a loss of function (LOF) or a gain of function (GOF) in the respective ionic current (Kim and Kang, 2021; Kullmann, 2002; Musto et al., 2020; Waxman, 2011).”
BackgroundConsiderations and recent advances in nanoscale interfaces with neuronal and cardiac networks
Tchoe, Y., Lee, J., Liu, R., Bourhis, A. M., Vatsyayan, R., Tonsfeldt, K. J., & Dayeh, S. A. (2021) · Applied Physics Reviews · doi:10.1063/5.0052666 · Cited by 15
In Vitro Folding of KvAP, a Voltage Gated K+ Channel
Devaraneni, P. K., & Valiyaveetil, F. I. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2011.11.1461 · Cited by 15
Otalora, L. F. P., Skinner, F., Oliveira, M. S., Farrell, B., Arshadmansab, M. F., Pandari, T., Garcia, I., Robles, L., Rosas, G., Mello, C. F., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.10.047 · Cited by 14
Spinocerebellar Ataxia Type 2 with Focal Epilepsy – An Unusual Association
Tan, N., Zhou, Y., Tan, A., Chong, S. S., & Lee, W. L. (2004) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v33n1p103 · Cited by 14
Chapter 13 The contributions of neurophysiology to clinical neurology
Berlucchi, G. (2009) · Handbook of clinical neurology · doi:10.1016/s0072-9752(08)02113-1 · Cited by 14
“More recently, the concept of neuronal channelopathies (Kullmann, 2002) has been introduced to refer to neural dysfunctions amenable to inherited or acquired mutations of both voltage-gated and ligand-gated ionic channels, with consequent alterations of channel function.”
BackgroundSCN5Asplicing variants and the possibility of predicting heart failure-associated arrhythmia
Gao, G., & Dudley, S. C. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.180 · Cited by 13
Migraine disease: evolution and progression
Buzzi, M. G., Cologno, D., & Formisano, R. (2005) · The Journal of Headache and Pain · doi:10.1007/s10194-005-0215-9 · Cited by 13
“, hemiplegic migraine is allelic with episodic shares common genetic assessment with ataxias and cerebellar disorders [1].”
BackgroundA bivalent remipede toxin promotes calcium release via ryanodine receptor activation
Maxwell, M. J., Thekkedam, C. G., Lamboley, C. R. H., Chin, Y. K. ‐., Crawford, T., Smith, J. J. L., Liu, J., Jia, X., Vetter, I., Laver, D. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36579-w · Cited by 12
Metadata
- Authors
- Kullmann, D. M.
- Affiliations
- UCL Queen Square Institute of Neurology (GB)
- Corresponding author
- Kullmann, Dimitri M.
- ORCID
- Kullmann, Dimitri M.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-06
- Volume
- 125
- Issue
- 6
- Pages
- 1177-1195
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2167538368
- Cited by
- 168
- References
- 143
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 11 · 2022: 4 · 2021: 5 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 2 · 2016: 4 · 2015: 2 · 2014: 3 · 2013: 7 · 2012: 6
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Keywords
- ion channel mutations, genetic epilepsy, voltage-gated ion channels, ligand-gated ion channels, episodic ataxia, calcium channel mutations, potassium channel mutations, familial hemiplegic migraine, coma, phenotypic convergence, phenotypic divergence
- MeSH terms
- Animals, Central Nervous System Diseases, Humans, Ion Channels, Mutation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.